Vnitr Lek 2017, 63(7-8):527-530 | DOI: 10.36290/vnl.2017.107

Infectious complications related to liver transplants

Vladimír Mejzlík*, Libuše Husová, Milan Kuman, Soňa Štěpánková, Jiří Ondrášek, Petr Němec
Centrum kardiovaskulární a transplantační chirurgie, Brno

Infection is a feared complication in the process of transplantation. The study discusses sources of infection, screening of infection and risk factors for infection, time occurrence of individual infections during the peritransplantation and posttransplantation course. It describes the most frequent forms of bacterial, viral and mycotic infections. It specifies efficient prophylactic measures that considerably reduce the risk of infection following liver transplantation.

Keywords: bacterial infection; cytomegalovirus (CMV); EB virus (EBV); hepatitis B (HBV); hepatitis C (HCV); liver transplantation; mycotic infection prophylaxis; risk factors; viral infection

Received: April 13, 2017; Accepted: June 20, 2017; Published: July 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mejzlík V, Husová L, Kuman M, Štěpánková S, Ondrášek J, Němec P. Infectious complications related to liver transplants. Vnitr Lek. 2017;63(7-8):527-530. doi: 10.36290/vnl.2017.107.
Download citation

References

  1. Sun HY, Cacciarelli TV, Singh N. Impact of pretransplant infections on clinical outcomes of liver transplant recipients. Liver Transplantation 2010; 16(2): 222-228. Dostupné z DOI: <http://dx.doi.org/10.1002/lt.21982>. Go to original source... Go to PubMed...
  2. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338(4): 1741-1751. Go to original source... Go to PubMed...
  3. Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol 2011; 3(4): 83-92. Dostupné z DOI: <http://dx.doi.org/10.4254/wjh.v3.i4.83>. Go to original source... Go to PubMed...
  4. Brayman KL, Stephanian E, Matas AJ et al. Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg 1992; 127(1): 38-48. Go to original source... Go to PubMed...
  5. Singh N, Wagener NM, Gayowski T et al. Trends in invasive fungal infections in liver transplant recipients: Correlation with evolution in transplant practices. Transplantation 2002; 73(1): 63-67. Go to original source... Go to PubMed...
  6. Eschenauer GA, Lam SW, Carver PL. Antifungal prophylaxis in liver transplant recipients. Liver Transplant 2009; 15(8): 842-858. Dostupné z DOI: <http://dx.doi.org/10.1002/lt.21826>. Erratum in Liver Transpl 2010; 16(6): 797-805. Go to original source... Go to PubMed...
  7. Fortun J, Martin-Davila P, Moreno S et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl 2002; 8(11): 1065-1070. Go to original source... Go to PubMed...
  8. Liang TJ, Ghany MG. Current and future therapies for hepatitis C virus infection. N Engl J Med 2013; 368(20): 1907-1917. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra1213651>. Go to original source... Go to PubMed...
  9. Kalil AC, Mindru C, Botha JF et al. Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir Prophylaxis: A systematic review and meta-analysis. Liver Transpl 2012; 18(12): 1440-1447. Dostupné z DOI: <http://dx.doi.org/10.1002/lt.23530>. Go to original source... Go to PubMed...
  10. Torre-Cisneros H, de la Mata M, Lopez-Cillero P et al. Effectiveness of daily low-dose cotrimoxazole prophylaxis for Pneumocystis carinii pneumonia in liver transplantation - an open clinical trial. Transplantation 1996; 62(10): 1519-1521. Go to original source... Go to PubMed...
  11. Holt D, Winston J, Busuttil R et al. Infections after Liver Transplantation. In: Ronald W. Busuttil RW, Klintmalm GB (eds).Transplantation of The Liver. 3rd ed. 2015: 1006-1030. ISBN: 978-1-4557-0268-8. Dostupné z DOI: <https://doi.org/10.1016/B978-1-4557-0268-8.12001-9>. Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.